James Maclean
Impact in
- Biotechnology top 2%
- Transgenic Plants and Applications
- Virology top 10%
Papers in
-
- Transgenic Plants and Applications 8
-
- Toxin Mechanisms and Immunotoxins 2
- T-cell and Retrovirus Studies 2
- Co-authors
- Anna‐Lise Williamson (6 shared papers)Edward P. Rybicki (5 shared papers)Inga I. Hitzeroth (2 shared papers)Adriaan Olivier (1 shared paper)Debbie Stewart (1 shared paper)Rainer Fischer (1 shared paper)T. W. Rademacher (1 shared paper)Ann E. Meyers (2 shared papers)
- Journals
- Journal of General Virology (2 papers)Frontiers in Immunology (2 papers)BMC Biotechnology (2 papers)Blood (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesSouth AfricaGermany
In The Last Decade
James Maclean
15 papers receiving 536 citations
Peers
Comparison fields: 5 of 60
- Biotechnology 290
- Virology 37
- Immunology 129
- Infectious Diseases 92
- Molecular Biology 291
Countries citing papers authored by James Maclean
This map shows the geographic impact of James Maclean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Maclean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Maclean more than expected).
Fields of papers citing papers by James Maclean
This network shows the impact of papers produced by James Maclean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Maclean. The network helps show where James Maclean may publish in the future.
Co-authors
The 25 scholars most cited alongside James Maclean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 182 | |
| 2 | 2008 | 77 | |
| 3 | 1997 | 74 | |
| 4 | 2010 | 37 | |
| 5 | 2012 | 34 | |
| 6 | 1999 | 32 | |
| 7 | 2011 | 31 | |
| 8 | 2009 | 28 | |
| 9 | 2005 | 15 | |
| 10 | 2015 | 13 | |
| 11 | 2014 | 13 | |
| 12 | 2020 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 1997 | 6 | |
| 15 | 2022 | 4 |
About James Maclean
James Maclean is a scholar working on Biotechnology, Immunology, Molecular Biology, Plant Science and Infectious Diseases, having authored 15 papers that have together received 559 indexed citations. Recurring topics across this work include Transgenic Plants and Applications (8 papers), Plant Virus Research Studies (5 papers), Animal Virus Infections Studies (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Cervical Cancer and HPV Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), T-cell and Retrovirus Studies (2 papers) and Reproductive tract infections research (2 papers). The work is most often cited by research in Biotechnology (290 citations), Virology (37 citations), Immunology (129 citations), Infectious Diseases (92 citations) and Molecular Biology (291 citations). James Maclean has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Anna‐Lise Williamson, Edward P. Rybicki, Inga I. Hitzeroth, Adriaan Olivier, Debbie Stewart, Rainer Fischer, T. W. Rademacher, Ann E. Meyers, Enid Shephard and Keith McCarthy. Their work appears in journals such as Journal of General Virology, Frontiers in Immunology, BMC Biotechnology, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.